|
Volumn 12, Issue 3, 1999, Pages 95-102
|
Mechanisms for resistance to anticancer agents and the reversal of the resistance
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
5 (4,6 DIMETHYL 1,3,2 DIOXAPHOSPHORINAN 2 YL) 2,6 DIMETHYL 4 (3 NITROPHENYL) 3 PYRIDINECARBOXYLIC ACID 2 (4 BENZHYDRYL 1 PIPERAZINYL)ETHYL ESTER P OXIDE;
ANION TRANSPORT PROTEIN;
ANTINEOPLASTIC AGENT;
BERAPROST;
CARRIER PROTEIN;
CYCLOSPORIN;
DRUG DERIVATIVE;
GLYCOPROTEIN P;
NICOTINIC ACID DERIVATIVE;
PHOSPHINE OXIDE DERIVATIVE;
PROSTACYCLIN;
RIBONUCLEOPROTEIN;
ANIMAL;
BINDING SITE;
CELL NUCLEUS;
CYTOPLASM;
DRUG EFFECT;
DRUG RESISTANCE;
HUMAN;
METABOLISM;
PHYSIOLOGY;
PROTEIN BINDING;
REVIEW;
TRANSPORT AT THE CELLULAR LEVEL;
ANIMALS;
ANION TRANSPORT PROTEINS;
ANTINEOPLASTIC AGENTS;
BINDING SITES;
BIOLOGICAL TRANSPORT;
CARRIER PROTEINS;
CELL NUCLEUS;
CYCLIC P-OXIDES;
CYCLOSPORINE;
CYTOPLASM;
DRUG RESISTANCE, NEOPLASM;
EPOPROSTENOL;
HUMANS;
NICOTINIC ACIDS;
P-GLYCOPROTEIN;
PROTEIN BINDING;
VAULT RIBONUCLEOPROTEIN PARTICLES;
|
EID: 0033182292
PISSN: 09147470
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (11)
|
References (10)
|